Abstract
Ovarian cancer is highly metastatic with a poor prognosis. The serine/threonine kinase, p70 S6 kinase (p70S6K), which is a downstream effector of phosphatidylinositol 3-kinase/Akt pathway, is frequently activated in ovarian cancer. Here, we show that p70S6K is a critical regulator of the actin cytoskeleton in the acquisition of the metastatic phenotype. This regulation is through two important activities: p70S6K acts as an actin filament cross-linking protein and as a Rho family GTPase-activating protein. Ectopic expression of constitutively active p70S6K in ovarian cancer cells induced a marked reorganization of the actin cytoskeleton and promoted directional cell migration. Using cosedimentation and differential sedimentation assays, p70S6K was found to directly bind to and cross-link actin filaments. Immunofluorescence studies showed p70S6K colocalized with cytochalasin D-sensitive actin at the leading edge of motile cells. The p70S6K did not affect the kinetics of spontaneous actin polymerization, but could stabilize actin filaments by the inhibition of cofilin-induced actin depolymerization. In addition, we showed that p70S6K stimulated the rapid activation of both Rac1 and Cdc42, and their downstream effector p21-activated kinase (PAK1), but not RhoA. Depletion of p70S6K expression or inhibition of its activity resulted in significant inhibition of actin cytoskeleton reorganization and reduced migration, with a concomitant reduction in Rac1, Cdc42 and PAK1 activation, confirming that the effect was p70S6K specific. Similarly, the actin cytoskeleton reorganization/migratory phenotype could be reversed by expression of dominant negative Rac1 and Cdc42, or inhibition of PAK1. These results reveal a new direction for understanding the oncogenic roles of p70S6K in tumor progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahmed N, Maines-Bandiera S, Quinn MA, Unger WG, Dedhar S, Auersperg N . (2006). Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 290: C1532–C1542.
Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK et al. (2004). AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor growth. Oncogene 23: 5853–5857.
Berven LA, Willard FS, Crouch MF . (2004). Role of the p70(S6K) pathway in regulating the actin cytoskeleton and cell migration. Exp Cell Res 296: 183–195.
Buick RN, Pullano R, Trent JM . (1985). Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 45: 3668–3676.
Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J et al. (2006). Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer 107: 1801–1811.
Chou MM, Blenis J . (1996). The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell 85: 573–583.
Corps AN, Sowter HM, Smith SK . (1997). Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-met. Int J Cancer 73: 151–155.
Dummler B, Ohshiro K, Kumar R, Field J . (2009). Pak protein kinases and their role in cancer. Cancer Metastasis Rev 28: 51–63.
Erickson JW, Cerione RA . (2004). Structural elements, mechanism, and evolutionary convergence of Rho protein-guanine nucleotide exchange factor complexes. Biochemistry 43: 837–842.
Filonenko VV, Tytarenko R, Azatyan SK, Savinskal LO, Gaydar YA, Gout IT et al. (2004). Immunohistochemical analysis of S6K1 and S6K2 localization in human breast tumors. Exp Oncol 26: 294–299.
Hall A . (1998). Rho GTPases and the actin cytoskeleton. Science 279: 509–514.
Hanein D, Matsudaira P, DeRosier DJ . (1997). Evidence for a conformational change in actin induced by fimbrin (N375) binding. J Cell Biol 139: 387–396.
Holmes GR, Goll DE, Suzuki A, Robson RM, Stromer MH . (1976). Effect of trypsin on rabbit skeletal-muscle alpha-actinin. Biochim Biophys Acta 446: 445–456.
Jefferies HBJ, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, Thomas G . (1997). Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70(S6k). EMBO J 16: 3693–3704.
Jemal A, Siegel R, Ward E, Hao YP, Xu JQ, Thun MJ . (2009). Cancer Statistics, 2009. CA-Cancer J Clin 59: 225–249.
Kislauskis EH, Zhu XC, Singer RH . (1994). Sequences responsible for intracellular-localization of beta-actin messenger-RNA also affect cell phenotype. J Cell Biol 127: 441–451.
Latham VM, Kislauskis EH, Singer RH, Ross AF . (1994). Beta-actin messenger-RNA localization is regulated by signal-transduction mechanisms. J Cell Biol 126: 1211–1219.
Liu LZ, Hu XW, Xia C, He J, Zhou Q, Shi X et al. (2006). Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1 alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic Biol Med 41: 1521–1533.
Nozawa H, Watanabe T, Nagawa H . (2007). Phosphorylation of ribosomal p70 S6 kinase and rapamycin sensitivity in human colorectal cancer. Cancer Lett 251: 105–113.
Olson MF, Ashworth A, Hall A . (1995). An essential role for Rho, Rac and Cdc42 GTPases in cell cycle progression through G1. Science 269: 1270–1272.
Pantaloni D, Le Clainche C, Carlier MF . (2001). Mechanism of actin-based motility. Science 292: 1502–1506.
Pawlak G, Helfman DM . (2001). Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev 11: 41–47.
Philp AJ, Campbell IG, Leet C, Vincan E, Rockman SP, Whitehead RH et al. (2001). The phosphatidylinositol 3′-kinase p85 alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res 61: 7426–7429.
Pon YL, Zhou HY, Cheung ANY, Ngan HYS, Wong AST . (2008). p70 S6 kinase promotes epithelial to mesenchymal transition through Snail induction in ovarian cancer cells. Cancer Res 68: 6524–6532.
Raftopoulou M, Hall A . (2004). Cell migration: Rho GTPases lead the way. Dev Biol 265: 23–32.
Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G et al. (2003). Cell migration: integrating signals from front to back. Science 302: 1704–1709.
Sahin F, Kannangai R, Adegbola O, Wang JZ, Su G, Torbenson M . (2004). mTOR and P70S6 kinase expression in primary liver neoplasms. Clin Cancer Res 10: 8421–8425.
Sander EE, van Delft S, ten Klooster JP, Reid T, van der Kammen RA, Michiels F et al. (1998). Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J Cell Biol 143: 1385–1398.
Sawada K, Radjabi AR, Shinomiya N, Kistner E, Kenny H, Becker AR et al. (2007). c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res 67: 1670–1679.
Schmidt A, Bickle M, Beck T, Hall MN . (1997). The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2. Cell 88: 531–542.
Schraml P, Schwerdtfeger G, Burkhalter F, Raggi A, Schmidt D, Ruffalo T et al. (2003). Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol 163: 985–992.
Shayesteh L, Lu YL, Kuo WL, Baldocchi R, Godfrey T, Collins C et al. (1999). PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21: 99–102.
Siu MK, Wong ES, Chan HY, Kong DS, Woo NW, Tam KF et al. (2009). Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion. Int J Cancer 127: 21–31.
Sowter HM, Corps AN, Smith SK . (1999). Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells. Int J Cancer 83: 476–480.
Takaishi K, Sasaki T, Kotani H, Nishioka H, Takai Y . (1997). Regulation of cell-cell adhesion by Rac and Rho small G proteins in MDCK cells. J Cell Biol 139: 1047–1059.
Theriault BL, Shepherd TG, Mujoomdar ML, Nachtigal MW . (2007). BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis 28: 1153–1162.
Wong AST, Roskelley CD, Pelech S, Miller D, Leung PCK, Auersperg N . (2004). Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation. Exp Cell Res 299: 248–256.
Zhou HY, Wong AST . (2006). Activation of p70(S6K) induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells. Endocrinology 147: 2557–2566.
Acknowledgements
We thank Dr N Auersperg, G Thomas and A Hall for providing cell lines and cDNA constructs. This work was supported by the Research Grant Council grant HKU 7599/05M and the HKU Outstanding Young Research Award (AST Wong).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Ip, C., Cheung, A., Ngan, H. et al. p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells. Oncogene 30, 2420–2432 (2011). https://doi.org/10.1038/onc.2010.615
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.615
Keywords
This article is cited by
-
LCRMP-1 is required for spermatogenesis and stabilises spermatid F-actin organization via the PI3K-Akt pathway
Communications Biology (2023)
-
Beyond controlling cell size: functional analyses of S6K in tumorigenesis
Cell Death & Disease (2022)
-
Erianthridin suppresses non-small-cell lung cancer cell metastasis through inhibition of Akt/mTOR/p70S6K signaling pathway
Scientific Reports (2021)
-
S6Ks isoforms contribute to viability, migration, docetaxel resistance and tumor formation of prostate cancer cells
BMC Cancer (2016)
-
TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial–mesenchymal transition
Cell Death & Disease (2016)